PDG14 COST-UTILITY OF DALBAVANCIN VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH ABSSSI IN ITALY

Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1028
https://www.valueinhealthjournal.com/article/S1098-3015(19)33406-0/fulltext
Title : PDG14 COST-UTILITY OF DALBAVANCIN VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH ABSSSI IN ITALY
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33406-0&doi=10.1016/j.jval.2019.09.1028
First page :
Section Title :
Open access? : No
Section Order : 10907
Categories :
Tags :
Regions :
ViH Article Tags :